Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

The matrix protein Fibulin-5 is at the interface of tissue stiffness and inflammation in fibrosis.

Nakasaki M, Hwang Y, Xie Y, Kataria S, Gund R, Hajam EY, Samuel R, George R, Danda D, M J P, Nakamura T, Shen Z, Briggs S, Varghese S, Jamora C.

Nat Commun. 2015 Oct 15;6:8574. doi: 10.1038/ncomms9574.

2.

Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.

Heo JH, Song JY, Jeong JY, Kim G, Kim TH, Kang H, Kwon AY, An HJ.

J Clin Pathol. 2016 Feb;69(2):109-16. doi: 10.1136/jclinpath-2015-203129. Epub 2015 Aug 6.

PMID:
26251522
3.

Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.

Chen X, Song X, Yue W, Chen D, Yu J, Yao Z, Zhang L.

Oncotarget. 2015 Jun 20;6(17):15022-34.

4.

Expression of fibulin-5 in the skin of patients with rectal prolapse.

Joshi HM, Gosselink MP, Smyth EA, Hompes R, Cunningham C, Lindsey I, Urban J, Jones OM.

Colorectal Dis. 2015 Nov;17(11):996-1001. doi: 10.1111/codi.12972.

PMID:
25891043
5.

Analysis of disease-associated protein expression using quantitative proteomics—fibulin-5 is expressed in association with hepatic fibrosis.

Bracht T, Schweinsberg V, Trippler M, Kohl M, Ahrens M, Padden J, Naboulsi W, Barkovits K, Megger DA, Eisenacher M, Borchers CH, Schlaak JF, Hoffmann AC, Weber F, Baba HA, Meyer HE, Sitek B.

J Proteome Res. 2015 May 1;14(5):2278-86. doi: 10.1021/acs.jproteome.5b00053. Epub 2015 Apr 6.

PMID:
25807371
6.

Gene expression levels of elastin and fibulin-5 according to differences between carotid plaque regions.

Sivrikoz E, Timirci-Kahraman Ö, Ergen A, Zeybek Ü, Aksoy M, Yanar F, İsbir T, Kurtoğlu M.

In Vivo. 2015 Mar-Apr;29(2):229-35.

PMID:
25792650
7.

Modeling autosomal recessive cutis laxa type 1C in mice reveals distinct functions for Ltbp-4 isoforms.

Bultmann-Mellin I, Conradi A, Maul AC, Dinger K, Wempe F, Wohl AP, Imhof T, Wunderlich FT, Bunck AC, Nakamura T, Koli K, Bloch W, Ghanem A, Heinz A, von Melchner H, Sengle G, Sterner-Kock A.

Dis Model Mech. 2015 Apr;8(4):403-15. doi: 10.1242/dmm.018960. Epub 2015 Feb 20.

8.

Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.

BMC Cancer. 2014 Dec 12;14:938. doi: 10.1186/1471-2407-14-938.

9.

Differential tolerance of 'pseudo-pathogenic' tryptophan residues in calcium-binding EGF domains of short fibulin proteins.

Nguyen A, Hulleman JD.

Exp Eye Res. 2015 Jan;130:66-72. doi: 10.1016/j.exer.2014.12.002. Epub 2014 Dec 3.

10.

Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts.

Groessl M, Slany A, Bileck A, Gloessmann K, Kreutz D, Jaeger W, Pfeiler G, Gerner C.

J Proteome Res. 2014 Nov 7;13(11):4773-82. doi: 10.1021/pr500727h. Epub 2014 Oct 3.

PMID:
25238572
11.

Elastin development-associated extracellular matrix constituents of subepithelial connective tissue in human pterygium.

Pérez-Rico C, Pascual G, Sotomayor S, Asúnsolo Á, Cifuentes A, García-Honduvilla N, Buján J.

Invest Ophthalmol Vis Sci. 2014 Sep 2;55(10):6309-18. doi: 10.1167/iovs.14-14214.

PMID:
25183766
12.

Dysregulated fibulin-5 expression and elastogenesis in COPD lungs: pyromaniac or fire fighter?

Brusselle G.

Thorax. 2015 Jan;70(1):1-2. doi: 10.1136/thoraxjnl-2014-205887. Epub 2014 Aug 7. No abstract available.

PMID:
25103011
13.
14.

A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD.

Brandsma CA, van den Berge M, Postma DS, Jonker MR, Brouwer S, Paré PD, Sin DD, Bossé Y, Laviolette M, Karjalainen J, Fehrmann RS, Nickle DC, Hao K, Spanjer AI, Timens W, Franke L.

Thorax. 2015 Jan;70(1):21-32. doi: 10.1136/thoraxjnl-2014-205091. Epub 2014 Jul 2.

PMID:
24990664
15.

Cutis laxa with pulmonary emphysema, conjunctivochalasis, nasolacrimal duct obstruction, abnormal hair, and a novel FBLN5 mutation.

Kantaputra PN, Kaewgahya M, Wiwatwongwana A, Wiwatwongwana D, Sittiwangkul R, Iamaroon A, Dejkhamron P.

Am J Med Genet A. 2014 Sep;164A(9):2370-7. doi: 10.1002/ajmg.a.36630. Epub 2014 Jun 24.

PMID:
24962763
16.

Fibulin-5 (FBLN5) gene polymorphism is associated with pelvic organ prolapse.

Khadzhieva MB, Kamoeva SV, Chumachenko AG, Ivanova AV, Volodin IV, Vladimirov IS, Abilev SK, Salnikova LE.

Maturitas. 2014 Aug;78(4):287-92. doi: 10.1016/j.maturitas.2014.05.003. Epub 2014 May 13.

PMID:
24917111
17.

Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies.

Papke CL, Yanagisawa H.

Matrix Biol. 2014 Jul;37:142-9. doi: 10.1016/j.matbio.2014.02.004. Epub 2014 Mar 6. Review.

18.

Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.

Hwang CF, Shiu LY, Su LJ, Yu-Fang Yin, Wang WS, Huang SC, Chiu TJ, Huang CC, Zhen YY, Tsai HT, Fang FM, Huang TL, Chen CH.

PLoS One. 2013 Dec 27;8(12):e84218. doi: 10.1371/journal.pone.0084218. eCollection 2013.

19.

The various Charcot-Marie-Tooth diseases.

Vallat JM, Mathis S, Funalot B.

Curr Opin Neurol. 2013 Oct;26(5):473-80. doi: 10.1097/WCO.0b013e328364c04b. Review.

PMID:
23945280
20.

Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers.

Djokic J, Fagotto-Kaufmann C, Bartels R, Nelea V, Reinhardt DP.

J Biol Chem. 2013 Aug 2;288(31):22821-35. doi: 10.1074/jbc.M112.439158. Epub 2013 Jun 19.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk